189 related articles for article (PubMed ID: 25010003)
1. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.
Ghany MG; Perrillo R; Li R; Belle SH; Janssen HL; Terrault NA; Shuhart MC; Lau DT; Kim WR; Fried MW; Sterling RK; Di Bisceglie AM; Han SH; Ganova-Raeva LM; Chang KM; Lok AS; ;
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):183-92. PubMed ID: 25010003
[TBL] [Abstract][Full Text] [Related]
2. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.
Brahmania M; Lombardero M; Hansen BE; Terrault NA; Lok AS; Perrillo RP; Belle SH; Di Bisceglie AM; Feld JJ; Lee WM; Fried MW; Janssen HLA;
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2541-2551.e2. PubMed ID: 30743006
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.
Lok AS; Ganova-Raeva L; Cloonan Y; Punkova L; Lin HS; Lee WM; Ghany MG;
J Viral Hepat; 2017 Nov; 24(11):1032-1042. PubMed ID: 28581155
[TBL] [Abstract][Full Text] [Related]
4. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
Ghany MG; King WC; Lisker-Melman M; Lok ASF; Terrault N; Janssen HLA; Khalili M; Chung RT; Lee WM; Lau DTY; Cloherty GA; Sterling RK
Hepatology; 2021 Nov; 74(5):2395-2409. PubMed ID: 34133774
[TBL] [Abstract][Full Text] [Related]
5. Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes.
Lau DTY; Ganova-Raeva L; Wang J; Mogul D; Chung RT; Lisker-Melman M; Chang KM; Shaikh OS; Janssen HLA; Wahed AS; Lok AS;
Hepatology; 2021 May; 73(5):1637-1651. PubMed ID: 32860463
[TBL] [Abstract][Full Text] [Related]
6. Children with Chronic Hepatitis B in the United States and Canada.
Schwarz KB; Cloonan YK; Ling SC; Murray KF; Rodriguez-Baez N; Schwarzenberg SJ; Teckman J; Ganova-Raeva L; Rosenthal P;
J Pediatr; 2015 Dec; 167(6):1287-1294.e2. PubMed ID: 26364985
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America.
Cooper SL; King WC; Mogul DB; Ghany MG; Schwarz KB;
J Viral Hepat; 2021 Jul; 28(7):1042-1056. PubMed ID: 33893706
[TBL] [Abstract][Full Text] [Related]
8. The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia.
Milosevic I; Delic D; Lazarevic I; Pavlovic IP; Korac M; Bojovic K; Jevtovic D
J Clin Virol; 2013 Sep; 58(1):54-8. PubMed ID: 23838671
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological, clinical, virological features of hepatitis B newly diagnosed in 2011 in Marseille University hospitals, southeastern France.
Moussa S; Brah S; Parola P; Gerolami R; Gamerre M; Boubli L; Ruiz JM; Ravaux I; Mokhtari S; Mancini J; Romera MH; Motte A; Tamalet C; Colson P
J Med Virol; 2016 May; 88(5):828-36. PubMed ID: 26439319
[TBL] [Abstract][Full Text] [Related]
10. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
[TBL] [Abstract][Full Text] [Related]
11. The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.
Tedder RS; Rodger AJ; Fries L; Ijaz S; Thursz M; Rosenberg W; Naoumov N; Banatvala J; Williams R; Dusheiko G; Chokshi S; Wong T; Rosenberg G; Moreea S; Bassendine M; Jacobs M; Mills PR; Mutimer D; Ryder SD; Bathgate A; Hussaini H; Dillon JF; Wright M; Bird G; Collier J; Anderson M; Johnson AM;
Clin Infect Dis; 2013 Apr; 56(7):951-60. PubMed ID: 23223601
[TBL] [Abstract][Full Text] [Related]
12. Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America.
Khalili M; Leonard KR; Ghany MG; Hassan M; Roberts LR; Sterling RK; Belle SH; Lok AS;
JAMA Netw Open; 2023 Apr; 6(4):e237018. PubMed ID: 37036707
[TBL] [Abstract][Full Text] [Related]
13. Role of serum dehydroepiandrosterone sulfate level on the clearance of chronic hepatitis B virus infection.
Wu JF; Tsai WY; Tung YC; Chen HL; Ni YH; Hsu HY; Chang MH
J Gastroenterol; 2014 May; 49(5):900-6. PubMed ID: 23728318
[TBL] [Abstract][Full Text] [Related]
14. A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infection.
Minuk GY; Macrury S; Uhanova J; Caouette S; Coleman N; Cummings K; Larke B; Vardy L; Triet Huyn C; Osiowy C
J Viral Hepat; 2013 Dec; 20(12):890-6. PubMed ID: 24304459
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatitis B virus genotypes/subgenotypes in 1,301 patients with chronic hepatitis B in North China.
Li XD; Wang L; Liu Y; Xu ZH; Dai JZ; Li L; Yao ZT; Xin SJ; Zhao JM; Xu DP
Chin Med J (Engl); 2011 Dec; 124(24):4178-83. PubMed ID: 22340383
[TBL] [Abstract][Full Text] [Related]
16. Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.
Feld JJ; Terrault NA; Lin HS; Belle SH; Chung RT; Tsai N; Khalili M; Perrillo R; Cooper SL; Ghany MG; Janssen HLA; Lok AS;
Hepatology; 2019 Jun; 69(6):2338-2348. PubMed ID: 30549279
[TBL] [Abstract][Full Text] [Related]
17. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
[TBL] [Abstract][Full Text] [Related]
18. Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.
Di Bisceglie AM; King WC; Lisker-Melman M; Khalili M; Belle SH; Feld JJ; Ghany MG; Janssen HLA; Lau D; Lee WM; Ling SC; Cooper S; Rosenthal P; Schwarz KB; Sterling RK; Teckman JH; Terrault N;
J Viral Hepat; 2019 Jul; 26(7):856-865. PubMed ID: 30974509
[TBL] [Abstract][Full Text] [Related]
19. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.
Preda CM; Popescu CP; Baicus C; Constantinescu I; Oproiu A; Voiosu T; Diculescu M; Negreanu L; Gheorghe L; Sporea I; Trifan A; Ceausu E; Proca D; Manuc M
J Viral Hepat; 2018 Jul; 25(7):834-841. PubMed ID: 29397016
[TBL] [Abstract][Full Text] [Related]
20. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia.
Zhou K; Wahed AS; Cooper S; Di Bisceglie AM; Fontana RJ; Ghany MG; Khalili M; Lok AS; Perrillo R; Lee WM; Lau DTY; Sterling R; Janssen HLA; Terrault NA
Am J Gastroenterol; 2019 Nov; 114(11):1753-1763. PubMed ID: 31658127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
